PET2-Adapted Therapy in Patients With Advanced-Stage Hodgkin Lymphoma Treated With Frontline ABVD: Searching for the Baby in the Bathwater [0.03%]
探索Bathwater中的Baby：一线ABVD方案后复发/难治的晚期霍奇金淋巴瘤患者的PET2指导下的个体化治疗策略研究
Antonio Pinto,Annarosa Cuccaro,Matteo Bonanni et al.
Antonio Pinto et al.
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell Lymphoma [0.03%]
伊布替尼联合苯达莫司汀和利妥昔单抗治疗复发/难治侵袭性B细胞淋巴瘤患者的效果
Meirav Kedmi,Elena Ribakovsy,Ohad Benjamini et al.
Meirav Kedmi et al.
Therapy for relapsed or refractory (R/R) aggressive B-cell non-Hodgkin lymphoma (aB-NHL) post autologous stem cell transplantation (ASCT) or in elderly patients can be challenging. In this single-center, single-arm, phase II clinical study,...
Clinical Trial
Hematological oncology. 2024 Nov;42(6):e70001. DOI:10.1002/hon.70001 2024
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study [0.03%]
一项关于大剂量阿霉素、长春花碱和他莫昔芬联合巩固放疗治疗晚期经典型霍奇金淋巴瘤的多中心真实世界研究取得了更好的疗效：针对一线老年患者的治疗方法
M Picardi,A Vincenzi,C Giordano et al.
M Picardi et al.
In elderly patients with high-risk classic Hodgkin lymphoma (c-HL), we evaluated the impact of a new modality treatment without bleomycin, that is, liposomal doxorubicin (NPLD)-based regimen plus consolidation radiotherapy of residual nodal...
Multicenter Study
Hematological oncology. 2024 Nov;42(6):e70003. DOI:10.1002/hon.70003 2024
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia [0.03%]
CLL中CAT rs1001179单核苷酸多态性与侵袭性的临床病程相关
Marilisa Galasso,Vittoria Salaorni,Riccardo Moia et al.
Marilisa Galasso et al.
Chronic lymphocytic leukemia (CLL) is characterized by an extremely variable clinical course. Although several parameters have been shown to be associated with clinical outcomes in patients with CLL, there remains substantial intragroup cli...
Isocitrate dehydrogenase 2 mutation promotes cytarabine resistance in acute myeloid leukemia by Warburg effect [0.03%]
缺氧诱导的IDH2突变通过瓦博格效应促进急性髓系白血病细胞阿糖胞苷耐药性
Jinrong Yang,Zixu Wang,Kun Wu et al.
Jinrong Yang et al.
Mutation of isocitrate dehydrogenase 2 (IDH2) is a key factor in promoting cytarabine (Ara-C) resistance in acute myeloid leukemia (AML), however the underly mechanism remains unclear. Acute myeloid leukemia cells, were cultured with either...
Allogeneic transplantation for adult T-cell leukemia/lymphoma in adolescent and young adults and young patients: A nationwide retrospective study by the ATL working group of the Japan society for transplantation and cellular therapy [0.03%]
日本移植和细胞治疗学会成人T细胞白血病/淋巴瘤工作组全国回顾性研究：异基因移植在青少年及年轻成年患者和年轻成人患者中的应用
Hidehiro Itonaga,Takuya Fukushima,Koji Kato et al.
Hidehiro Itonaga et al.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) provides durable remission for patients with adult T-cell leukemia/lymphoma (ATL); however, few studies have focused on post-transplant outcomes in ATL patients ≤49 years. To c...
Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study [0.03%]
REALYSA队列的Marginal Zone淋巴瘤患者的现实世界数据：REALMA研究
C Bommier,M Donzel,C Rossi et al.
C Bommier et al.
Marginal Zone Lymphoma (MZL) comprises three subtypes: extranodal MZL (EMZL), splenic MZL (SMZL) and nodal MZL (NMZL). Since clinical trials have limited representativeness, there is a need for real-world data (RWD) evidence in MZL. Real-wo...
Multicenter Study
Hematological oncology. 2024 Nov;42(6):e3314. DOI:10.1002/hon.3314 2024
Characterizing second line and beyond therapies for primary central nervous system lymphomas [0.03%]
原发中枢神经系统淋巴瘤二线和二线以后治疗的现状及对策分析
Brian Primeaux,Chelsea Luo,Erin K Yeung et al.
Brian Primeaux et al.
Primary central nervous system (CNS) lymphoma (PCNSL) is a rare and aggressive lymphoma that affects the CNS without other systemic involvement. High-dose methotrexate (HDMTX)-based regimens are recommended frontline treatment, followed by ...
Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35) [0.03%]
FIGO分期系统在女性生殖道原始淋巴瘤中的更优预后准确性：一项回顾性研究（IELSG35）
Maria Cristina Pirosa,Sara Steffanoni,Anna Vanazzi et al.
Maria Cristina Pirosa et al.
Primary lymphoma of the female genital tract (PLFGT) is a rare type of extranodal lymphoma. In this retrospective study from the International Extranodal Lymphoma Study Group, we analyzed clinical data from 60 women diagnosed with PLFGT bet...
Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications [0.03%]
意大利伦巴第地区慢性髓性白血病患病率的直接测定及其全球影响
N Polverelli,M Anghilieri,C Elena et al.
N Polverelli et al.
Lombardy represents the largest region of Italy by population, with almost 10 million residents, a dimension similar to a medium size country like Sweden or Belgium. The CML subcommittee of the Lombardy Hematology Network (REL-CML) conducte...
Multicenter Study
Hematological oncology. 2024 Sep;42(5):e3311. DOI:10.1002/hon.3311 2024